Affiliations: 1st Department of Medicine, University of Pecs, Medical School, Pecs, Hungary | Department of Radiology, University of Pecs, Medical School, Pecs, Hungary | Department of Biochemistry and Medical Chemistry, University of Pecs, Medical School, Pecs, Hungary
Note: [] Corresponding author: Eszter Szabados, MD, PhD, 1st Department of Medicine, University of Pecs, Medical School, Ifjusag street 13, 7624-Pecs, Hungary, Tel.: +36 72 536 000; Fax: +36 72 536 148; E-mail: eszter.szabados@aok.pte.hu
Abstract: Several beneficial effects of resveratrol (RES), a natural antioxidant present in red wine have already been described. The aim of our study was to investigate if RES had a clinically measurable cardioprotective effect in patients after myocardial infarction. In this double-blind, placebo controlled trial 40 post-infarction Caucasian patients were randomized into two groups. One group received 10 mg RES capsule daily for 3 months. Systolic and diastolic left ventricular function, flow-mediated vasodilation (FMD), several laboratory and hemorheological parameters were measured before and after the treatment. Left ventricular ejection fraction showed an increasing tendency (ns) by RES treatment. However, left ventricular diastolic function was improved significantly (p < 0.01) by RES. A significant improvement in endothelial function measured by FMD was also observed (p < 0.05). Low-density lipoprotein (LDL) level significantly decreased (p < 0.05) in the RES treated group. Red blood cell deformability decreased and platelet aggregation increased significantly in the placebo group (p < 0.05), while resveratrol treatment has prevented these unfavourable changes. Concerning other measured parameters no significant changes were observed neither in placebo nor in RES group. Our results show that resveratrol improved left ventricle diastolic function, endothelial function, lowered LDL-cholesterol level and protected against unfavourable hemorheological changes measured in patients with coronary artery disease (CAD).
Keywords: Resveratrol, cardioprotection, endothelial dysfunction, platelet aggregation, red blood cell deformability, left ventricular diastolic function
